New Era Mediequip Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 24-10-2024
- Paid Up Capital ₹ 0.60 M
as on 24-10-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.27 Cr
as on 24-10-2024
- Revenue -64.06%
(FY 2023)
- Profit -76.11%
(FY 2023)
- Ebitda -37.73%
(FY 2023)
- Net Worth 7.07%
(FY 2023)
- Total Assets -27.30%
(FY 2023)
About New Era Mediequip
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹2.27 Cr.
Ramish Ansari, Ali Ahmed, and Shahnaz Ansari serve as directors at the Company.
- CIN/LLPIN
U33119RJ2009PTC030497
- Company No.
030497
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does New Era Mediequip Private Limited offer?
New Era Mediequip Private Limited offers a wide range of products and services, including Oxygen Flow Meter, BPC Flowmeter, Medical Gas Outlet, Industrial Pipe & Tube Fittings, Gas Pipe Fittings, Machines & Equipments, Industrial Machinery, Surgical & ICU Equipments, Operation Theater Equipments, Oxygen Mask, Flowmeter & Humidifier Bottle.
Who are the key members and board of directors at New Era Mediequip?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramish Ansari  | Director | 04-Aug-2020 | Current |
| Ali Ahmed | Director | 30-Aug-2024 | Current |
| Shahnaz Ansari | Director | 15-Dec-2009 | Current |
Financial Performance of New Era Mediequip.
New Era Mediequip Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 64.06% decrease. The company also saw a substantial fall in profitability, with a 76.11% decrease in profit. The company's net worth moved up by a moderate rise of 7.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New Era Mediequip?
In 2023, New Era Mediequip had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Feb 2024 | ₹1.57 Cr | Open |
Others Creation Date: 10 Nov 2020 | ₹7.00 M | Open |
How Many Employees Work at New Era Mediequip?
Unlock and access historical data on people associated with New Era Mediequip, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Era Mediequip, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Era Mediequip's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
